🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
134.00
-1.95 (-1.43%)
At close: Nov 18, 2026, 4:00 PM EST
133.76
-0.24 (-0.18%)
Pre-market: Nov 19, 2026, 8:22 AM EST

Axsome Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-157.29-183.17-287.22-239.24-187.13-130.4
Depreciation & Amortization
10.589.067.966.834.40.08
Other Amortization
0.651.32.642.571.481.08
Stock-Based Compensation
99.6793.7585.2262.6237.7320.8
Other Operating Activities
-8.988.7129.5150.373.34-0.1
Change in Accounts Receivable
-146.61-82.46-47.18-57.12-37.7-
Change in Inventory
-16.9-10.660.74-8.16-1.33-
Change in Accounts Payable
41.85-6.4631.322.0725.46-0.36
Change in Other Net Operating Assets
95.2576.5348.634.9737.240.68
Operating Cash Flow
-81.77-93.41-128.41-145.08-116.51-108.23
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.84-0.48-0.27-0.58-0.7-0.31
Cash Acquisitions
-----53-
Investing Cash Flow
-0.84-0.48-0.27-0.58-53.7-0.31

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-330-8545-
Long-Term Debt Repaid
--334.11-0.99---
Total Debt Repaid
-283.84-334.11-0.99---
Net Debt Issued (Repaid)
-3.84-4.11-0.998545-
Issuance of Common Stock
102.84127.4671.46271.17250.0111.84
Repurchase of Common Stock
-15.02-7.11-3.95-1.84-0.53-0.18
Other Financing Activities
-12.77-14.78-8.68-23.32-9.9-0.53
Financing Cash Flow
71.2101.4757.84331.01284.5811.13

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-11.417.58-70.84185.35114.37-97.4

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-82.61-93.89-128.68-145.66-117.21-108.53
Free Cash Flow Growth
------
Free Cash Flow Margin
-9.55%-14.70%-33.36%-53.83%-234.25%-
Free Cash Flow Per Share
-1.60-1.89-2.69-3.21-2.88-2.88
Levered Free Cash Flow
-24.38-29.42-38.1-87.21-43.82-59.52
Unlevered Free Cash Flow
-16.96-20.77-27.25-77.26-39.26-57.04

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
12.1614.6319.6916.737.694.63
Change in Working Capital
-26.41-23.0633.48-28.2423.670.32
SEC Filings: 10-K · 10-Q